Studying the relationship between cell cycle and Alzheimer's disease by gold nanoparticle probes

Anal Biochem. 2015 Nov 15:489:32-7. doi: 10.1016/j.ab.2015.08.014. Epub 2015 Aug 20.

Abstract

In this study, a simple gold nanoparticle (GNP)-based colorimetric assay has been developed for studying the relationship between cell cycle and β-amyloid peptide (Aβ, the biomarker of Alzheimer's disease [AD]) expression level. It was found that Aβ expression of neuronal cells (e.g., SHG-44 cell line) is strongly dependent on cell cycle phases; that is, the Aβ expression level was highest when cells were arrested in the G1/S phase by thymidine and was lowest when they were arrested in the G2/M phase by nocodazole. This finding may improve the understanding of AD pathology and provide a new tool for anti-dementia drug development.

Keywords: Alzheimer's disease; Cell cycle; Gold nanoparticle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / analysis*
  • Amyloid beta-Peptides / metabolism
  • Antimetabolites / pharmacology
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Biotinylation
  • Cell Line, Tumor
  • Down-Regulation / drug effects
  • G1 Phase* / drug effects
  • G2 Phase / drug effects
  • Gold / analysis
  • Gold / chemistry
  • Humans
  • Immobilized Proteins / chemistry
  • Immobilized Proteins / metabolism
  • Metal Nanoparticles / analysis*
  • Metal Nanoparticles / chemistry
  • Molecular Probes / analysis
  • Molecular Probes / chemistry
  • Molecular Probes / metabolism
  • Nerve Tissue Proteins / analysis*
  • Nerve Tissue Proteins / metabolism
  • Neurons / chemistry
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / pathology*
  • Peptide Fragments / analysis
  • Peptide Fragments / metabolism
  • Streptavidin / chemistry
  • Streptavidin / metabolism
  • Surface Properties
  • Tubulin Modulators / pharmacology
  • Up-Regulation* / drug effects

Substances

  • Amyloid beta-Peptides
  • Antimetabolites
  • Biomarkers
  • Immobilized Proteins
  • Molecular Probes
  • Nerve Tissue Proteins
  • Peptide Fragments
  • Tubulin Modulators
  • amyloid beta-protein (1-16)
  • Gold
  • Streptavidin